marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 02-13-2025
Vertex Pharmaceuticals Incorporated Financial Ratios 2011-2025 | VRTX
Annual Financial Ratios Vertex Pharmaceuticals Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-223.1 | 30.3 | 22.9 | 24.2 | 22.6 | 50.2 | 22.7 | 157.3 | -184.3 | -39.4 | -35.1 | -41.5 | -88.4 | 240.7 |
P/S |
10.8 | 11.1 | 8.5 | 7.5 | 9.9 | 14.2 | 15.6 | 16.7 | 12.1 | 21.2 | 44.7 | 15.2 | 6.2 | 5.0 |
EPS |
-2.1 | 14.1 | 13.0 | 9.1 | 10.4 | 4.6 | 8.2 | 1.1 | -0.5 | -2.3 | -3.1 | -2.0 | -0.5 | 0.1 |
EV (Enterprise Value) |
121 B | 105 B | 69.8 B | 53.1 B | 58.5 B | 58.3 B | 46.7 B | 41.3 B | 21 B | 22.6 B | 26.5 B | 18.9 B | 10.5 B | 7.88 B |
EBITDA per Share |
-0.1 | 15.6 | 17.4 | 11.3 | 11.4 | 5.1 | 2.9 | 1.83 | 0.297 | -1.67 | -2.46 | -0.672 | 0.2 | 1.25 |
EV/EBITDA |
18.2 | 18.1 | 42.8 | 61.0 | 87.6 | 276.3 | -53.4 | -44.2 | -118.5 | 221.3 | 27.4 | |||
PEG |
-16.94 | 0.63 | 0.37 | 0.16 | 0.17 | -1.13 | 0.03 | 0.48 | -2.3 | -1.49 | 0.6 | 0.14 | 0.2 | 2.32 |
P/B |
7.3 | 6.2 | 5.5 | 5.6 | 7.1 | 9.7 | 10.7 | 20.3 | 15.4 | 20.0 | 23.6 | 13.6 | 7.9 | 7.4 |
P/CF |
-242.6 | 31.0 | 18.4 | 21.4 | 18.9 | 39.6 | 40.5 | 70.8 | 115.0 | -53.3 | -45.9 | -179.4 | 48.1 | 144.8 |
ROE % |
-3.26 | 20.59 | 23.88 | 23.19 | 31.22 | 19.34 | 47.28 | 12.90 | -8.37 | -50.87 | -67.38 | -32.81 | -8.95 | 3.06 |
ROA % |
-2.38 | 15.92 | 18.30 | 17.44 | 23.07 | 14.15 | 33.57 | 7.43 | -3.87 | -22.26 | -31.63 | -19.19 | -3.88 | 1.34 |
ROCE % |
-1.42 | 21.80 | 30.96 | 27.55 | 32.88 | 17.21 | 12.95 | 14.34 | 0.53 | -23.32 | -32.62 | -10.38 | 0.18 | 12.24 |
Current Ratio |
3.7 | 4.4 | 4.3 | 4.0 | 3.8 | 3.6 | 3.4 | 3.3 | 2.3 | 2.8 | 4.2 | 4.0 | 3.7 | 3.4 |
DSO |
52.5 | 55.6 | 52.7 | 48.7 | 44.7 | 55.5 | 57.1 | 56.4 | 43.8 | 66.9 | 56.6 | 25.8 | 34.2 | 47.4 |
DIO |
231.8 | 173.4 | 137.5 | 127.9 | 111.1 | 111.6 | 110.8 | 148.4 | 134.6 | 167.7 | 184.6 | 39.6 | 39.7 | 509.7 |
DPO |
92.8 | 96.7 | 84.3 | 70.7 | 60.2 | 58.4 | 98.9 | 98.2 | 106.6 | 219.7 | 426.1 | 138.2 | 132.1 | 338.4 |
Operating Cycle |
284.4 | 229.0 | 190.2 | 176.7 | 155.8 | 167.2 | 167.9 | 204.8 | 178.4 | 234.6 | 241.3 | 65.4 | 74.0 | 557.1 |
Cash Conversion Cycle |
191.6 | 132.3 | 105.9 | 106.0 | 95.6 | 108.8 | 69.0 | 106.6 | 71.8 | 14.9 | -184.8 | -72.8 | -58.1 | 218.7 |
All numbers in USD currency
Quarterly Financial Ratios Vertex Pharmaceuticals Incorporated
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
4.05 | -13.92 | 4.26 | - | 4.01 | 3.55 | 2.72 | - | 3.63 | 3.17 | 2.99 | - | 3.3 | 0.26 | 2.52 | 2.32 | 2.56 | 3.22 | 2.32 | 2.26 | 0.22 | 1.04 | 1.05 | 6.08 | 0.51 | 0.82 | 0.83 | 0.4 | -0.41 | 0.07 | 1.01 | 0.13 | -0.16 | -0.26 | -0.17 | -0.3 | -0.39 | -0.78 | -0.83 | -0.74 | -0.72 | -0.68 | -1 | 0.19 | -0.54 | -0.26 | -1.43 | -0.35 | -0.27 | -0.31 | 0.44 | 0.76 | 1.06 | -0.85 | -0.87 |
EBITDA per Share |
- | - | 4.62 | - | - | - | 3.18 | - | 4.82 | 4.32 | 4.22 | - | 4.44 | -0.15 | 3.53 | 2.87 | 2.89 | 2.97 | 2.88 | 2.14 | 0.7 | 1.27 | 1.19 | 0.5 | 1.02 | 0.82 | 0.57 | 0.5 | -1.12 | 0.33 | 1.16 | 0.16 | 0.11 | 0.14 | 0.01 | -0.22 | -0.1 | -0.58 | -0.65 | -0.64 | -0.4 | -0.64 | -0.86 | -0.04 | -0.4 | -0.12 | -1.94 | -0.36 | 0.12 | 0.03 | 0.48 | 1.08 | 1.17 | -0.73 | -0.75 |
ROE % |
-5.44 | -5.85 | 24.39 | 17.04 | 24.18 | 25.05 | 25.92 | 20.92 | 29.86 | 31.66 | 25.59 | 16.94 | 23.89 | 22.64 | 31.55 | 31.22 | 33.84 | 27.11 | 22.74 | 20.22 | 45.59 | 49.08 | 51.52 | 55.87 | 25.87 | 16.36 | 9.53 | 12.99 | 10.87 | 12.59 | 6.12 | -9.69 | -20.38 | -27.15 | -41.66 | -59.19 | -67.78 | -73.47 | -68.21 | -68.70 | -49.00 | -42.34 | -31.72 | -32.81 | -43.70 | -40.30 | -42.59 | -10.71 | 17.07 | 50.93 | 35.31 | 3.76 | 28.10 | -22.12 | -22.38 |
ROA % |
-3.79 | -3.72 | 18.63 | 12.95 | 18.52 | 19.33 | 20.17 | 16.26 | 23.01 | 18.85 | 19.40 | 12.69 | 17.83 | 16.76 | 23.34 | 23.07 | 24.94 | 19.96 | 16.05 | 14.15 | 31.96 | 33.33 | 33.44 | 33.57 | 11.59 | 6.62 | 3.81 | 7.43 | 5.73 | 7.29 | 4.56 | -3.87 | -7.96 | -10.42 | -15.75 | -22.27 | -26.88 | -30.36 | -29.63 | -31.63 | -22.16 | -20.23 | -15.86 | -19.19 | -23.86 | -20.59 | -20.48 | -3.88 | 6.08 | 18.19 | 12.65 | 1.34 | 10.03 | -7.90 | -7.99 |
ROCE % |
-4.22 | -5.07 | 25.35 | 18.32 | 26.97 | 29.33 | 31.96 | 27.46 | 38.53 | 40.94 | 31.26 | 20.54 | 29.12 | 25.80 | 34.48 | 32.88 | 33.36 | 27.25 | 24.31 | 20.57 | 14.39 | 19.83 | 20.94 | 21.76 | 25.08 | 1.93 | -1.91 | 6.08 | 3.30 | 17.76 | 15.45 | 0.86 | -8.28 | -14.11 | -32.61 | -49.67 | -58.25 | -64.03 | -62.61 | -64.41 | -50.88 | -46.76 | -33.43 | -44.97 | -51.97 | -42.97 | -40.58 | 0.23 | 36.44 | 63.96 | 43.96 | 14.47 | 27.41 | -21.08 | -20.32 |
Current Ratio |
3.4 | 3.8 | 4.5 | 4.4 | 4.2 | 4.2 | 4.2 | 4.3 | 4.5 | - | 4.3 | 4.0 | 4.1 | 4.0 | 3.9 | 3.8 | 3.8 | 3.8 | 3.8 | 3.7 | 3.7 | 3.7 | 3.7 | 3.5 | 3.5 | 3.5 | 3.5 | 2.4 | 2.4 | 2.4 | 2.4 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 | 1.9 | 1.9 | 2.4 | 2.4 | 2.4 | 2.4 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 |
DSO |
56.1 | 59.5 | 56.9 | - | 56.9 | 56.8 | 57.4 | - | 27.1 | 26.9 | 52.9 | - | 46.7 | 48.5 | 49.3 | 49.6 | 52.5 | 53.0 | 45.7 | 40.9 | 60.9 | 61.4 | 55.5 | 43.0 | 47.6 | 49.7 | 49.2 | 39.4 | 44.4 | 47.2 | 30.8 | 39.9 | 44.3 | 42.5 | 43.0 | 38.0 | 51.8 | 97.6 | 83.5 | 48.0 | 38.7 | 50.1 | 62.2 | 22.2 | 35.2 | 25.1 | 31.8 | 39.1 | 38.9 | 31.2 | 33.9 | 29.7 | 25.4 | 146.1 | - |
DIO |
231.8 | 212.0 | 206.7 | - | 185.0 | 168.3 | 170.2 | - | 61.2 | 59.1 | 128.4 | - | 126.4 | 124.2 | 137.5 | 126.2 | 137.6 | 138.8 | 125.9 | 82.6 | 115.9 | 112.6 | 140.0 | 92.8 | 102.0 | 108.7 | 150.5 | 121.4 | 140.0 | 143.3 | 183.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
84.1 | 83.3 | 95.4 | - | 105.8 | 101.5 | 107.2 | - | 20.0 | 30.2 | 68.4 | - | 49.3 | 51.1 | 67.1 | 69.7 | 76.0 | 76.7 | 68.2 | 43.2 | 60.6 | 58.9 | 95.3 | 82.8 | 91.0 | 97.0 | 117.8 | 80.3 | 92.7 | 94.8 | 131.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
287.8 | 271.4 | 263.6 | - | 241.8 | 225.1 | 227.7 | - | 88.3 | 85.9 | 181.3 | - | 173.1 | 172.7 | 186.8 | 175.8 | 190.1 | 191.8 | 171.6 | 123.5 | 176.7 | 174.0 | 195.5 | 135.8 | 149.7 | 158.4 | 199.7 | 160.8 | 184.4 | 190.5 | 214.7 | 39.9 | 44.3 | 42.5 | 43.0 | 38.0 | 51.8 | 97.6 | 83.5 | 48.0 | 38.7 | 50.1 | 62.2 | 22.2 | 35.2 | 25.1 | 31.8 | 39.1 | 38.9 | 31.2 | 33.9 | 29.7 | 25.4 | 146.1 | - |
Cash Conversion Cycle |
203.7 | 188.1 | 168.2 | - | 136.1 | 123.7 | 120.5 | - | 68.3 | 55.7 | 112.9 | - | 123.8 | 121.6 | 119.7 | 106.1 | 114.1 | 115.1 | 103.5 | 80.3 | 116.1 | 115.1 | 100.2 | 52.9 | 58.6 | 61.4 | 81.8 | 80.5 | 91.8 | 95.7 | 83.2 | 39.9 | 44.3 | 42.5 | 43.0 | 38.0 | 51.8 | 97.6 | 83.5 | 48.0 | 38.7 | 50.1 | 62.2 | 22.2 | 35.2 | 25.1 | 31.8 | 39.1 | 38.9 | 31.2 | 33.9 | 29.7 | 25.4 | 146.1 | - |
All numbers in USD currency